Description:
Home Page: www.newamsterdampharma.com
Gooimeer 2-35
Naarden,
1411 DC
Netherlands
Phone:
31 35 206 2971
Officers
| Name | Title |
|---|---|
| Dr. Michael Harvey Davidson FACC, Facc., Facp., M.D. | CEO, Pres, Exec. Board Member & Director |
| Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D. | Founder, Chief Scientific Officer & Member of Exec. Board |
| Ms. Louise Kooij | CFO, Treasurer, Member of Exec. Board & Director |
| Mr. Douglas F. Kling | COO, VP & Director |
| Mr. Jim Jacobson | Chief Legal Officer & Sec. |
| Ms. Lina Gugucheva | Chief Bus. Officer |
| Dr. Sheng Cui Ph.D. | VP & Head of Chemistry Manufacturing and Controls (CMC) |
| Ms. Annie Neild | VP & Head of Regulatory Affairs |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2022-11-23 |
| Fiscal Year End: | December |
| Full Time Employees: | 22 |